MELISSA JAMISON: Open Payments
NPI 1164680039 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 56 payments from 11 companies in 2025. Trend: 2023 $849 · 2024 $1,109 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 24 | $373 |
| ABBVIE INC. | 13 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $56 |
| Janssen Biotech, Inc. | 3 | $56 |
| GENZYME CORPORATION | 2 | $50 |
| Medtronic, Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
Products named: REZDIFFRA, RINVOQ, EOHILIA, CREON, XIFAXAN, TREMFYA, DUPIXENT, INTERSTIM.
Industry payments across PA — which companies pay providers there.
